FIELD: medicine.
SUBSTANCE: invention refers to medicine. A method involves in the fact that autologous cell cultures of patient's fibroblasts enriched with multipotent mesenchymal stem cells (MMSCs) are once transplanted on a wound surface. A portion of the culture MMSCs makes 5 to 15%. The cells are applied on the wound dropwise and fixed on the tissue defect with the use of a fibrine carrier and protected with a bandage made of platelet-rich plasma.
EFFECT: method provides reduced length of treatment; it is safe and high-effective.
2 dwg, 1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR THERAPY OF SKIN DAMAGES AND BIOTRANSPLANT THEREFOR | 2014 |
|
RU2588835C1 |
| METHOD FOR CELL THERAPY OF AGE-RELATED CHANGES OF SKIN | 2014 |
|
RU2582289C1 |
| BIOTRANSPLANT, METHOD FOR MAKING THEREOF AND METHOD OF TREATING DEGENERATIVE AND TRAUMATIC DISEASES OF MAXILLOFACIAL BONE TISSUE | 2008 |
|
RU2380105C1 |
| METHOD FOR PREPARING CORNEAL BIOTRANSPLANT | 2011 |
|
RU2505303C2 |
| CHRONIC WOUND AND/OR WOUND CHAMBER HEALING TECHNIQUE | 2012 |
|
RU2512681C2 |
| TREATMENT METHOD OF PURULENT-NECROTIC WOUNDS | 2019 |
|
RU2727867C1 |
| BIOTRANSPLANT FOR RECOVERY OF BONE TISSUE VOLUME IN CASE OF DEGENERATIVE DISEASES AND TRAUMATIC INJURIES OF BONES AND METHOD OF OBTAINING THEREOF | 2012 |
|
RU2530622C2 |
| SKIN REPAIR METHOD | 2019 |
|
RU2731313C1 |
| METHOD FOR TREATMENT OF PATIENTS WITH CONGENITAL EPIDERMOLYSIS BULLOSA BY COMBINED USE OF HUMAN ALLOGENEIC FIBROBLASTS AND LIVING SKIN EQUIVALENT | 2020 |
|
RU2779997C2 |
| METHOD OF OBTAINING AND USING MESENCHYMAL STEM CELL SPHEROIDS FOR; TREATMENT OF SKIN INJURIES | 2022 |
|
RU2812015C1 |
